Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
compounding
Health Tech
Hims & Hers eyes $6.5B revenue target by 2030
The online health and wellness company's quarterly profit soared to $50 million, up 4x compared to a profit of $11 million a year prior.
Heather Landi
May 5, 2025 5:00pm
Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s
Feb 21, 2025 4:30pm
Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle
Feb 13, 2025 8:00am
Found introducing oral dissolvable GLP-1 tablet
Jan 8, 2025 9:00am
Hims & Hers to buy compounding pharmacy to make weight loss meds
Aug 6, 2024 7:00am
Hims & Hers adds GLP-1 injections to its weight loss program
May 20, 2024 9:00am